Aitken M, de St Jorre J, Pagliari C, Jepson R, Cunningham-Burley S (2016) Public responses to the sharing and linkage of health data for research purposes: a systematic review and thematic synthesis of qualitative studies. BMC Med Ethics 17(1):73. https://doi.org/10.1186/s12910-016-0153-x

Article  PubMed  PubMed Central  Google Scholar 

Arbour L, Cook D (2006) DNA on loan: issues to consider when carrying out genetic research with aboriginal families and communities. Community Genet 9(3):153–160. https://doi.org/10.1159/000092651

Article  PubMed  Google Scholar 

Beaton A, Hudson M, Milne M et al (2017) Engaging Māori in biobanking and genomic research: a model for biobanks to guide culturally informed governance, operational, and community engagement activities. Genet Med 19:345–351. https://doi.org/10.1038/gim.2016.111

Article  PubMed  Google Scholar 

Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, Singh AB, Ruaño G, Mueller DJ, Tsermpini EE, Brown JT, Bell GC, Leeder JS, Gaedigk A, Scott SA, Klein TE, Caudle KE, Bishop JR (2023) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther 114(1):51–68. https://doi.org/10.1002/cpt.2903

Article  PubMed  PubMed Central  CAS  Google Scholar 

Carroll SR, Herczog E, Hudson M, Russell K, Stall S (2021) Operationalizing the CARE and FAIR principles for Indigenous data futures. Sci Data 8(1):108. https://doi.org/10.1038/s41597-021-00892-0

Article  PubMed  PubMed Central  Google Scholar 

Carroll SR, Plevel R, Jennings LL, Garba I, Sterling R, Cordova-Marks FM, Hiratsuka V, Hudson M, Garrison NA (2022) Extending the CARE principles from tribal research policies to benefit sharing in genomic research. Front Genet 13:1052620. https://doi.org/10.3389/fgene.2022.1052620

Article  PubMed  PubMed Central  Google Scholar 

Claw KG, Dorr CR, Woodahl EL (2024) Implementing community-engaged pharmacogenomics in Indigenous communities. Nat Commun 15(1):920

Article  PubMed  PubMed Central  CAS  Google Scholar 

D’Angelo CS, Hermes A, McMaster CR, Prichep E, Richer É, van der Westhuizen FH, Repetto GM, Mengchun G, Malherbe H, Reichardt JKV, Arbour L, Hudson M, du Plessis K, Haendel M, Wilcox P, Lynch SA, Rind S, Easteal S, Estivill X, Thomas Y, Baynam G (2020) Barriers and considerations for diagnosing rare diseases in Indigenous populations. Front Pediatr 8:579924. https://doi.org/10.3389/fped.2020.579924

Article  PubMed  PubMed Central  Google Scholar 

El Rouby N, Alrwisan A, Langaee T, Lipori G, Angiolillo DJ, Franchi F, Riva A, Elsey A, Johnson JA, Cavallari LH, Winterstein AG (2020) Clinical utility of pharmacogene panel-based testing in patients undergoing percutaneous coronary intervention. Clin Transl Sci 13(3):473–481. https://doi.org/10.1111/cts.12729

Article  PubMed  PubMed Central  Google Scholar 

Evans W, Meslin EM, Kai J, Qureshi N (2024) Precision medicine - are we there yet? A narrative review of precision medicine’s applicability in primary care. J Pers Med 14(4):418. https://doi.org/10.3390/jpm14040418

Article  PubMed  PubMed Central  Google Scholar 

Garrison NA, Hudson M, Ballantyne LL, Garba I, Martinez A, Taualii M, Arbour L, Caron NR, Rainie SC (2019) Genomic research through an indigenous lens: understanding the expectations. Annu Rev Genomics Hum Genet 20:495–517. https://doi.org/10.1146/annurev-genom-083118-015434

Article  PubMed  CAS  Google Scholar 

Gladding P, White H, Webster M, Prasugrel (2010) Māori, and personalised medicine in New Zealand. N Z Med J 123(1310):86–90

PubMed  Google Scholar 

Helsby NA (2016) CYP2C19 and CYP2D6 genotypes in Pacific peoples. Br J Clin Pharmacol 82(5):1303–1307. https://doi.org/10.1111/bcp.13045

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A (2015) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther 98(2):127–34. https://doi.org/10.1002/cpt.147

Article  PubMed  CAS  Google Scholar 

Hitchman L, Kerekere TWA, Miller AL, Goodin E, Koia C, Watson H, King F, Robertson SP, Wilcox P, Kennedy MA (2026) Allelic diversity of the pharmacogenes CYP2D6 and CYP2C19 in Māori from Te Tairāwhiti, Aotearoa New Zealand. Front Genet 17:1668409. https://doi.org/10.3389/fgene.2026.1668409

Article  PubMed  PubMed Central  Google Scholar 

Hudson M, Southey K, Uerata L, Beaton A, Milne M, Russell K, Smith B, Wilcox P, Toki V, Cheung M (2016a) Key informant views on biobanking and genomic research with Māori. N Z Med J 129(1447):29–42

PubMed  Google Scholar 

Hudson M, Beaton A, Milne M, Port W, Russell K, Smith B et al (2016b) Te Mata Ira: Guidelines for Genomic Research With Māori. Hamilton: Māori and Indigenous Governance Centre. Available online at https://www.waikato.ac.nz/data/assets/pdf_file/0018/321534/Te-Mata-Ira-Genome-Research-Guidelines.pdf

Hudson M, Garrison NA, Sterling R, Caron NR, Fox K, Yracheta J, Anderson J, Wilcox P, Arbour L, Brown A, Taualii M, Kukutai T, Haring R, Te Aika B, Baynam GS, Dearden PK, Chagné D, Malhi RS, Garba I, Tiffin N, Bolnick D, Stott M, Rolleston AK, Ballantyne LL, Lovett R, David-Chavez D, Martinez A, Sporle A, Walter M, Reading J, Carroll SR (2020) Rights, interests and expectations: Indigenous perspectives on unrestricted access to genomic data. Nat Rev Genet 21(6):377–384. https://doi.org/10.1038/s41576-020-0228-x. Epub 2020 Apr 6

Article  PubMed  CAS  Google Scholar 

Larsen PD, Johnston LR, Holley A, La Flamme AC, Smyth L, Chua EW et al (2015) Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population. Intern Med J 45:537–545. https://doi.org/10.1111/imj.12713

Article  PubMed  CAS  Google Scholar 

Lea RA, Roberts RL, Green MR, Kennedy MA, Chambers GK (2008) Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori. N Z Med J 121:33–37 PMID: 18584050

PubMed  Google Scholar 

Lee CR, Luzum JA, Sangkuhl K, Gammal RS, Sabatine MS, Stein CM, Kisor DF, Limdi NA, Lee YM, Scott SA, Hulot JS, Roden DM, Gaedigk A, Caudle KE, Klein TE, Johnson JA, Shuldiner AR (2022) Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update. Clin Pharmacol Ther 112(5):959–967. https://doi.org/10.1002/cpt.2526

Article  PubMed  PubMed Central  CAS  Google Scholar 

Martin J, Williams AK, Klein MD, Sriramoju VB, Madan S, Rossi JS, Clarke M, Cicci JD, Cavallari LH, Weck KE, Stouffer GA, Lee CR (2020) Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting. Genet Med 22(1):160–169. https://doi.org/10.1038/s41436-019-0611-1

Article  PubMed  CAS  Google Scholar 

Panattoni L, Brown PM, Te Ao B, Webster M, Gladding P (2012) The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation. PharmacoEconomics 30(11):1067–1084. https://doi.org/10.2165/11591510-000000000-00000

Article  PubMed  Google Scholar 

Petrović J, Pešić V, Lauschke VM (2020) Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe. Eur J Hum Genet 28(1):88–94. https://doi.org/10.1038/s41431-019-0480-8

Article  PubMed  CAS  Google Scholar 

Robertson SP, Hindmarsh JH, Berry S, Cameron VA, Cox MP, Dewes O, Doughty RN, Gray G, Jacobsen JC, Laurence A, Matisoo-Smith E, Morton S, Shelling AN, Sika-Paotonu D, Rolleston A, Skinner JR, Snell RG, Sporle A, Print C, Merriman TR, Hudson M, Wilcox P (2018) Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New Zealand. N Z Med J 131(1480):81–89 PMID: 30118371

PubMed  Google Scholar 

Rye CE, Puketapu-Watson H, Wihongi H, Aika BT, Macartney-Coxson D, de Ligt J, Print CG, Le Quesne Stabej P, Tsai P, Curran B, Jones N, Huh J, Perkins EO, Pestle M, Zhao K, Halytskyy Y, Robertson SP, Halliday BJ, Goodin E, Markie DM, Lamont A, Wilcox P (2025) Rakeiora Genomics Platform: a pathfinder for genomic medicine research in Aotearoa New Zealand. J R Soc N Z 55(6):2481–2505. https://doi.org/10.1080/03036758.2025.2469626

Article  PubMed  PubMed Central  Google Scholar 

Udoewa V (2022) An introduction to radical participatory design: decolonising participatory design processes. Des Sci 8:e31. https://doi.org/10.1017/dsj.2022.24

Article  Google Scholar 

Wilcox PL, Charity JA, Roberts MR, Tauwhare S, Tipene-Matua B, Kereama‐Royal I, Moke‐Delaney P (2008) A values‐based process for cross‐cultural dialogue between scientists and Māori. J R Soc N Z 38(3):215–227. https://doi.org/10.1080/03014220809510553

Article  Google Scholar